Everyone is asleep so will post more info as it comes to hand
16:15 NOVEL HEPARANASE INHIBITOR PI-88 EXTENDS DISEASE FREE SURVIVAL IN A RANDOMIZED PHASE II ADJUVANT CLINICAL TRIAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) AFTER CURATIVE RESECTION